Latest Heart failure Stories
PHA and its Scientific Leadership Council have spearheaded a quality improvement initiative to accredit Pulmonary Hypertension Centers of Care.
Takeda Stresses Continued Confidence in ACTOS DEERFIELD, Ill. and OSAKA, Japan, Sept.
researchers say more than an hour of moderate or half an hour of vigorous exercise per day may lower your risk of heart failure by 46 percent.
O'Hara lost two siblings to genetic heart failure when he faced dying of the same condition. The SynCardia Heart implant bridged him to a matching donor heart transplant.
HOUSTON, Sept. 2, 2014 /PRNewswire/ -- Cyberonics, Inc. (NASDAQ: CYBX), today announced results from the ANTHEM-HF clinical study.
Phase II feasibility trial provides first randomized sham-controlled data using vagus nerve stimulation to treat heart failure MARLBOROUGH, Mass., Aug.
-- LCZ696 mortality benefit exceeded what was achieved with enalapril, an ACE-inhibitor, when replacing enalapril combined with current treatment
- Study showed significantly more HF-REF patients on LCZ696 regimen were alive, had fewer hospitalizations than those given enalapril regimen(1) EAST HANOVER, N.J., Aug.
PHA has endorsed the American College of Chest Physicians guidelines for the management and treatment of pulmonary arterial hypertension in adults. Silver Spring,
The Tucson company manufactures the Total Artificial Heart, the world's only approved device that eliminates the source of end-stage biventricular failure, and the Freedom portable driver. TUCSON,
Circulation is a scientific journal published by Lippincott Williams & Wilkins on behalf of the American Heart Association. In 2008 the journal added six subspecialty publications: Circulation: Arrhythmia and Electrophysiology, Circulation: Heart Failure, Circulation: Cardiovascular Imaging, Circulation: Cardiovascular Interventions, Circulation: Cardiovascular Quality and Outcomes, and Circulation: Cardiovascular Genetics. Circulation publishes articles related to research in and the...